, 1995; Geiger et al, 1999; Weissenmayer et al, 2002; Gao et al

, 1995; Geiger et al., 1999; Weissenmayer et al., 2002; Gao et al., 2004). Challenging of some bacteria with low pH conditions can cause the modification of already existing membrane Target Selective Inhibitor Library molecular weight lipids, such as the formation of lysyl-phosphatidylglycerol from phosphatidylglycerol

or the hydroxylation of OLs (Rojas-Jiménez et al., 2005; Sohlenkamp et al., 2007; González-Silva et al., 2011; Vences-Guzmán et al., 2011). The capacity to form OLs is apparently widely distributed in eubacteria, but so far, OLs have not been detected in archaea and eukaryotes (López-Lara et al., 2003; Geiger et al., 2010). They contain a 3-hydroxy fatty acyl group that is attached in amide linkage to the α-amino group of ornithine. A second fatty acyl group, the so-called

piggy-back fatty acid, is ester-linked to the 3-hydroxy position of the first fatty acid (Knoche & Shively, 1972; Geiger et al., 1999). In some bacteria, OLs can be modified by hydroxylation in one or more positions. In recent years, several genes coding for OL hydroxylases have been identified. OLs can be hydroxylated in the ester-linked fatty acid, the amide-linked fatty acid, and the ornithine moiety (Rojas-Jiménez et al., 2005; González-Silva et al., 2011; Vences-Guzmán et al., 2011). In Gluconobacter cerinus, OLs hydroxylated in the C-2 position of the ester-linked fatty acid can be modified with a taurine residue that is amide-linked to the α-carboxy group of ornithine. This tauro-OL is also called cerilipin after the bacterial species from which it was isolated (Tahara et al., b). Although OLs are present in both membranes of Gram-negative bacteria, they are more abundant in the outer click here membrane (Dees

& Shively, 1982; Palacios-Chaves et al., 2011; Vences-Guzmán et al., 2011). Structurally similar lipids in which other amino acids are present instead of ornithine have been described. A lysine lipid has been described in an Agrobacterium tumefaciens strain (Tahara et al., b), glycine lipids were detected in Cytophaga johnsonae and Cyclobacterium marinus (Kawazoe et al., 1991; Batrakov et al., 1999), glutamine pheromone lipids were described in Rhodobacter sphaeroides (Zhang et al., 2009, 2011), and serineglycine lipids (SGLs) were isolated from the opportunistic pathogen Flavobacterium meningosepticum (Kawai et al., 1988; Shiozaki et al., b). The biosynthesis of the unmodified OL (sometimes also called S1 (Rojas-Jiménez et al., 2005)) occurs in two steps. The genes coding for the acyltransferase activities OlsB and OlsA required for OL biosynthesis were first discovered in the α-proteobacterium Sinorhizobium meliloti (Weissenmayer et al., 2002; Gao et al., 2004). In the first step, the N-acyltransferase OlsB is responsible for the transfer of a 3-hydroxy fatty acyl group from 3-hydroxy fatty acyl-acyl carrier protein (ACP) to the α-amino group of ornithine, thereby forming lyso-ornithine lipid (LOL) (Gao et al., 2004).

001 mg kg−1 The levels of DON, 3ADON, 15ADON, and NIV were deter

001 mg kg−1. The levels of DON, 3ADON, 15ADON, and NIV were determined in pooled grain samples by GC-MS as previously described by Eskola et al. (2001). Each pooled sample (100 g) contained kernels pooled from c. 500 wheat heads per sample. Each sample was analyzed once. The limits of quantitation were 0.01 mg kg−1 for DON and its derivatives and 0.03 mg kg−1 for NIV. The relationships between the quantitated DNA

and trichothecene concentrations in grain samples were determined by Pearson’s correlation analysis find more using statistica software (Data Analysis Software System, version 6.1; StatSoft Inc., 2003, http://www.statsoft.com). The quantitation of transcripts of tri4, tri5, and tri11 genes located in the 12-gene core tri cluster (Brown et al., 2004) was evaluated using TaqMan probes. The proposed

trichothecene biosynthetic pathway in Fusarium has been presented in Foroud & Eudes (2009). The analyzed genes encode the first steps of the type B trichothecene biosynthesis pathway and are representative of the initial flux of the biosynthetic pathway. Tables 2 and 3 show fold-change values representing tri up-regulation in F. graminearum isolates treated with azoles as compared to nontreated control. The tri transcript levels were always higher in cultures supplemented with sublethal concentrations of azoles, although in some cases, fold-change values were not significantly selleck altered [P(H1) = 0.001]. Among the tri transcripts analyzed of all studied isolates, the amount of tri4 transcript was the highest during the culture process followed by tri11 and tri5 (data not shown). It should be noted that the tri transcript levels in nontreated samples differed among the tested DON and NIV chemotypes. The tri transcript levels of DON chemotypes were at a similar and higher level than in the NIV chemotype (data Branched chain aminotransferase not shown). Notably, the tri transcript levels seemed to be related to the type of azole used. Within DON chemotypes, the amount of tri transcripts treated with tebuconazole was higher compared to samples treated with propiconazole; however, such a relation was not clear

for the NIV chemotype (Tables 2 and 3). In an independent experiment, the levels of trichothecenes (DON, 3ADON, 15ADON, NIV, and 4ANIV) were determined in 14-day-old cultures supplemented or not with different concentrations of azoles (Table 2 and 3). Isolate 1002T, identified with qPCR assay as 3ADON genotype, accumulated DON and higher amounts of 3ADON. Isolate 1001T, determined to be of the 15ADON genotype, produced DON and lower amounts of 3ADON and 15ADON. Isolate 0357, predicted with qPCR assay as an NIV producer, accumulated NIV, 4ANIV. For 3ADON chemotype, an increase in DON and 3ADON was revealed in samples treated with all sublethal concentrations of propiconazole. However, all samples of 15ADON chemotype exhibited decreased accumulation of trichothecenes as compared to N.T.C.

001 mg kg−1 The levels of DON, 3ADON, 15ADON, and NIV were deter

001 mg kg−1. The levels of DON, 3ADON, 15ADON, and NIV were determined in pooled grain samples by GC-MS as previously described by Eskola et al. (2001). Each pooled sample (100 g) contained kernels pooled from c. 500 wheat heads per sample. Each sample was analyzed once. The limits of quantitation were 0.01 mg kg−1 for DON and its derivatives and 0.03 mg kg−1 for NIV. The relationships between the quantitated DNA

and trichothecene concentrations in grain samples were determined by Pearson’s correlation analysis CH5424802 using statistica software (Data Analysis Software System, version 6.1; StatSoft Inc., 2003, http://www.statsoft.com). The quantitation of transcripts of tri4, tri5, and tri11 genes located in the 12-gene core tri cluster (Brown et al., 2004) was evaluated using TaqMan probes. The proposed

trichothecene biosynthetic pathway in Fusarium has been presented in Foroud & Eudes (2009). The analyzed genes encode the first steps of the type B trichothecene biosynthesis pathway and are representative of the initial flux of the biosynthetic pathway. Tables 2 and 3 show fold-change values representing tri up-regulation in F. graminearum isolates treated with azoles as compared to nontreated control. The tri transcript levels were always higher in cultures supplemented with sublethal concentrations of azoles, although in some cases, fold-change values were not significantly C59 wnt price altered [P(H1) = 0.001]. Among the tri transcripts analyzed of all studied isolates, the amount of tri4 transcript was the highest during the culture process followed by tri11 and tri5 (data not shown). It should be noted that the tri transcript levels in nontreated samples differed among the tested DON and NIV chemotypes. The tri transcript levels of DON chemotypes were at a similar and higher level than in the NIV chemotype (data PLEKHB2 not shown). Notably, the tri transcript levels seemed to be related to the type of azole used. Within DON chemotypes, the amount of tri transcripts treated with tebuconazole was higher compared to samples treated with propiconazole; however, such a relation was not clear

for the NIV chemotype (Tables 2 and 3). In an independent experiment, the levels of trichothecenes (DON, 3ADON, 15ADON, NIV, and 4ANIV) were determined in 14-day-old cultures supplemented or not with different concentrations of azoles (Table 2 and 3). Isolate 1002T, identified with qPCR assay as 3ADON genotype, accumulated DON and higher amounts of 3ADON. Isolate 1001T, determined to be of the 15ADON genotype, produced DON and lower amounts of 3ADON and 15ADON. Isolate 0357, predicted with qPCR assay as an NIV producer, accumulated NIV, 4ANIV. For 3ADON chemotype, an increase in DON and 3ADON was revealed in samples treated with all sublethal concentrations of propiconazole. However, all samples of 15ADON chemotype exhibited decreased accumulation of trichothecenes as compared to N.T.C.

Members of the Guideline Writing Group declared their conflicts o

Members of the Guideline Writing Group declared their conflicts of interests prior to the commencement of the writing process, and if a vote was necessary any member whose declared interests made this inappropriate did not participate. BHIVA hepatitis coinfection guidelines for hepatitis B and C were last published in 2010 [4]. For the 2013 guidelines the literature search dates were 1 January 2009 to 30 October 2012, and included Medline, Embase and the

Cochrane library. Abstracts from selected conferences (see Appendix 2) were searched between 1 January 2009 and 30 October 2012. For each topic and health care question, evidence was identified and evaluated by Guideline Writing Group members with expertise in that field. Using the modified GRADE system (Appendix 1), panel members were responsible for assessing and grading the quality of buy INCB024360 evidence for predefined outcomes across studies and developing and grading the strength of recommendations. An important aspect of evaluating evidence is an understanding of the design and analysis of clinical trials including the use of surrogate marker data. For a number of questions, GRADE evidence profile and summary of findings tables were constructed using predefined and rated treatment outcomes (Appendix KU-60019 molecular weight 2) to achieve consensus for key recommendations and aid transparency of process. Prior to final approval by the Writing

Group the guidelines were published online for public consultation and Cell press external peer review commissioned. BHIVA views the involvement of patient and community representatives in the guideline development process as essential. The Writing Group included one patient representative who was involved in all aspects of the guideline development process and was responsible for liaising with all interested patient groups. The GRADE Working Group [3] has developed an approach to grading evidence that moves from initial reliance

on study design to consider the overall quality of evidence across outcomes. BHIVA has adopted the modified GRADE system for the Association’s guideline development. The advantages of the modified GRADE system are: (i) the grading system provides an informative, transparent summary for clinicians, patients and policy makers by combining an explicit evaluation of the strength of the recommendation with a judgement of the quality of the evidence for each recommendation; (ii) the two-level grading system of recommendations has the merit of simplicity and provides clear direction to patients, clinicians and policy makers. A Grade 1 recommendation is a strong recommendation to do (or not do) something, where benefits clearly outweigh risks (or vice versa) for most, if not all, patients. Most clinicians and patients would want to follow a strong recommendation unless there is a clear rationale for an alternative approach. A strong recommendation usually starts with the standard wording ‘We recommend’.

The total time per home per day spent giving medicines varied fro

The total time per home per day spent giving medicines varied from 2.5 to 5.8 hours. A summary of medication activities at Table 1: Summary of medication-related activities and interruptions aggregated from four care homes Med. Round Residents (n) Time (mins) Interruptions (n) Doses administered (n) Mean no. doses per resident Mean no. interruptions per 100 doses Mean

no. interruptions per hour of med. round P *Mean was calculated only for 3 homes because consent from residents in one home was restricted to observing medicine rounds only – i.e. not for reviewing individual medication administration records. An average rate of PD0325901 molecular weight one interruption every 12 minutes during medicine rounds seems alarmingly high considering the potential for making a mistake is greater when being distracted. However, carers may consider personal care and social interaction to be equally important to residents and therefore accept interruptions during medicine rounds as being a normal part of their caring role. In stark contrast with evidence cited in the CHUMS report, care staff subjectively believed that the risk of making an error was low

which may result in errors remaining undetected. However, some staff in our study experienced considerable anxiety over the possibility of making a mistake with medication. A worthy subject for future research would therefore be to appraise what is considered to be an appropriate balance between avoiding medication click here errors whilst taking into account the competing social care priorities that are important in care Celecoxib homes. 1. Alldred DP et al (2009). Care Home Use of Medicines Study (CHUMS)). Medication errors in nursing and residential care homes – prevalence, consequences, causes and solutions. Universities of London, Leeds

and Surrey. Pamela Mills1,2, Anita Weidmann2, Derek Stewart2 1NHS Ayrshire and Arran, Ayrshire, UK, 2Robert Gordon University, Aberdeen, UK Semi-structured interviews were conducted with key hospital staff regarding their experiences of paper based prescribing systems and future expectations of electronic prescribing Multiple concerns and bad experiences were reported at every stage of the patient journey by all professional staff groups. The implementation of hospital electronic prescribing and medicine administration (HEPMA) was eagerly anticipated as a patient safety solution although many were cautious about impending changes to familiar practices. Hospital electronic prescribing and medicine administration (HEPMA) has been implemented into several UK hospitals with a lack of published formal evaluation. A recent systematic review advocates further research of information technology (IT) communication systems versus traditional, paper based systems, advising that organisations implementing such systems undertake formal research evaluation1.

Laser Doppler flowmetry revealed rapid light-evoked increases in

Laser Doppler flowmetry revealed rapid light-evoked increases in ocular blood flow that occurred prior to the increase in Vi/Vc neural activity. Synaptic blockade of the Vi/Vc region by cobalt chloride prevented light-evoked increases in tear volume, whereas blockade at the more caudal spinomedullary junction (Vc/C1) had no effect. In summary, Vi/Vc neurons encoded bright light intensity SB203580 and were inhibited by drugs that alter blood flow to the eye. These results support the hypothesis that light-responsive neurons at the Vi/Vc transition region are critical for ocular-specific functions such as reflex lacrimation, whereas neurons at the caudal

Vc/C1 junction region

probably serve other aspects of ocular nociception. “
“While most drugs of abuse increase dopamine neurotransmission, rapid neurochemical measurements show that different drugs evoke distinct dopamine release patterns within the nucleus accumbens. Rapid changes in dopamine concentration following psychostimulant administration have been well studied; however, such changes have never been examined following opioid delivery. Here, we provide novel measures of rapid www.selleckchem.com/products/epacadostat-incb024360.html dopamine release following intravenous infusion of two opioids, morphine and oxycodone, in drug-naïve rats using fast-scan cyclic voltammetry and rapid (1 min) microdialysis coupled with high-performance liquid chromatography – tandem mass spectrometry (HPLC-MS). In addition to measuring rapid dopamine transmission, microdialysis HPLC-MS measures changes in GABA, glutamate, monoamines, monoamine metabolites and several other neurotransmitters. Although both opioids increased dopamine release in the nucleus accumbens, their patterns of drug-evoked dopamine transmission differed dramatically. Oxycodone evoked Idoxuridine a robust and stable increase in dopamine concentration and a robust increase in the frequency and amplitude of phasic dopamine release events. Conversely, morphine evoked a brief (~ 1 min) increase in dopamine that

was coincident with a surge in GABA concentration and then both transmitters returned to baseline levels. Thus, by providing rapid measures of neurotransmission, this study reveals previously unknown differences in opioid-induced neurotransmitter signaling. Investigating these differences may be essential for understanding how these two drugs of abuse could differentially usurp motivational circuitry and powerfully influence behavior. “
“Department of Physiology, Nihon University School of Dentistry, Chiyoda-ku, Tokyo, Japan Orexin-A (OxA) is synthesized in posterior and lateral regions of the hypothalamus and contributes to homeostatic regulation of body functions including pain modulation.

, 2001; Tomsheck et al, 2010) The assays were conducted by remo

, 2001; Tomsheck et al., 2010). The assays were conducted by removing a 2.5-cm-wide strip of agar from the mid-portion of a standard Petri plate of PDA, creating two isolated MS-275 halves of agar. The fungus was inoculated onto one semi-circular agar piece and incubated at 23 °C for 10 days to allow for optimum production of volatile compounds. Test pathogens were inoculated onto the semi-circular section of agar opposite the semi-circular section inoculated with Ut-1. The plate was then wrapped with a single piece of parafilm and incubated at 23 °C for 24 h. Growth

of filamentous fungi was quantitatively assessed based on multiple measurements of growth extending from the edge of the inoculum plugs comparable with corresponding controls as described by Strobel et al. (2001). All tests were conducted in triplicate. Analysis of gases in the air space above the culture grown for 12 days at 23 ± 2 °C on PDA was undertaken using the solid phase microextraction fiber technique (Strobel et al., 2001). First, a baked ‘Solid Phase Micro Extraction’ syringe (Supelco) consisting of 50/30 divinylbenzene/carburen Epigenetic Reader Domain inhibitor on polydimethylsiloxane on a stable

flex fiber was placed through a small hole drilled in the side of the Petri plate and exposed to the vapor phase for 45 min. The syringe was then inserted into the splitless injection port of a Hewlett Packard 6890 gas chromatograph containing a 30 m × 0.25 mm inner diameter ZB Wax capillary column with a film thickness of 0.50 μm. The column was programmed as follows: 30 °C for 2 min followed by and increase to 220 °C at 5 °C min−1. The carrier gas was ultrahigh-purity helium (local distributor) and Reverse transcriptase the initial column head pressure was 50 kPa. Before trapping the volatiles, the fiber was conditioned at 240 °C for 20 min under a flow of helium gas. A 30-s injection time was used to introduce

the sample fiber into the chromatograph. The gas chromatograph was interfaced to a Hewlett Packard 5973 mass-selective detector (mass spectrometer) operating at unit resolution. The spectrometer was scanned at 2.5 scans s−1 over a mass range of 35–360 a.m.u. Data acquisition and data processing were performed on the Hewlett Packard chemstation software system. Initial identification of the compounds produced by the endophyte was made via library comparison using the National Institute of Standards and Technology (NIST) database, and all chemical compounds described in this report use the NIST database chemical terminology. As far as possible, authenticity of each compound identified by GC/MS was reconfirmed by GC/MS of authentic standards. Standard compounds were obtained from Sigma-Aldrich and run in a comparable manner as the fungal samples.

However, it remains possible that KS may impart an independent

However, it remains possible that KS may impart an independent Cyclopamine in vitro risk of mortality, as 91% of KS-related mortality occurred in the group with disseminated disease, similar to mortality rates observed in other studies [13-16]. Other studies have noted that improved immunological and virological responses are associated with clinical responses to KS [15]. However, our observation that the median CD4 count at the time of diagnosis for the patients with incident KS was 158 cells/μL compared with 83 cells/μL at baseline implies that

the risk for developing KS continues for some time, even with some degree of immune recovery. Other studies have shown the impact of HAART on KS in HIV-infected patients [17-19]. However, we had the opportunity to examine both risk factors for KS and clinical outcomes among patients predominantly treated with NNRTI-based regimens in a KS endemic country. The fact that regression rates in our study

are similar to those published for industrialized countries, selleck inhibitor where clinical responses range from 67 to 85% [8, 9], should be somewhat reassuring to patients and physicians who do not have easy access to specific anti-neoplastic therapy or PI-based HAART regimens. Less than half of the patients in this study were able to access any chemotherapy for KS, and only four completed a full course of treatment, which suggests that NNRTI-based HAART may be adequate therapy for most patients who develop Y-27632 2HCl KS when starting or while receiving HAART. Nevertheless, our study has a number of limitations. Because of the relatively small number of KS patients, we may have lacked sufficient power to detect other risk factors for

KS. This also limited our ability to ascertain differential response rates to different HAART regimens. In many instances we found factors that had ORs or HRs much greater than or less than 1, but with very wide confidence intervals. In particular, we had very few individuals who were switched from NNRTI-based regimens to PI-based regimens, which greatly limited our ability to detect differences in outcomes associated with these regimen changes. Furthermore, subjects were not randomly assigned to switch treatment and the lack of a significant difference in outcomes associated with treatment switching may have been attributable to other confounding factors. However, despite these limitations, these results are somewhat reassuring to patients and clinicians who may not have access to more expensive specific anti-neoplastic KS treatment or PI-based regimens. In conclusion, the use of NNRTI-based HAART regimens appears to induce remission of KS in HIV-infected patients in Uganda, although mortality associated with KS was still very high.

Through neuronal apoptosis induction by shifting mature cerebella

Through neuronal apoptosis induction by shifting mature cerebellar granule neurons to low-potassium medium, we have demonstrated that nuclear liver activator protein 1 expression decreases and its phosphorylation disappears, whereas liver inhibitory protein levels

increase in the nuclear fraction, suggesting a pro-survival role for liver activator protein transcriptional activation and a pro-apoptotic role for liver inhibitory protein transcriptional inhibition. To confirm this, we transfected cerebellar granule neurons with plasmids expressing buy GSK1120212 liver activator protein 1, liver activator protein 2, or liver inhibitory protein respectively, and observed that both liver activator proteins, which increase GDC-0941 molecular weight CCAAT-dependent transcription, but not liver inhibitory protein, counteracted apoptosis, thus demonstrating the pro-survival role of liver activator proteins. These data significantly improve our current understanding of the role of CCAAT enhancer-binding protein β in neuronal survival/apoptosis. CCAAT enhancer binding protein

(C/EBP) β belongs to a transcription factor family (C/EBP α–ζ) whose members contain a basic leucine-zipper domain for DNA binding and dimerization (Nerlov, 2008). Homodimeric and heterodimeric interactions occur among members of this family. C/EBP β exists in three isoforms generated from a single mRNA by leaky ribosome scanning: 38-kDa liver activator protein (LAP) 1 (LAP1), 35-kDa LAP2, and 21-kDa liver inhibitory protein (LIP). LAP1 and LAP2 contain both the transactivation and basic leucine-zipper domains, whereas LIP lacks the transactivation domain and forms non-functional heterodimers with LAP1 and LAP2 (Descombes

& Schibler, 1991; Ossipow et al., 1993). These transcription factors undergo post-translational modifications such as phosphorylation and sumoylation, as well Carnitine palmitoyltransferase II as subcellular translocation, which regulate transcriptional function (Nerlov, 2008; Kowenz-Leutz et al., 2010). C/EBPs have been extensively studied, owing to their importance in several cellular processes and in various diseases, including cancer. C/EBP β has multiple roles: it may inhibit or promote cell proliferation or differentiation, as well as survival or apoptosis, depending on the cell context and expressed isoforms (Sebastian & Johnson, 2006; Nerlov, 2007; Li et al., 2008; Ramathal et al., 2010). In the liver, LAP arrests cell cycle progression, whereas LIP induces hepatocyte proliferation (Buck et al., 1994). Moreover, LAP Thr217 phosphorylation in the mouse protein (Ser105 in rat) is required for hepatocyte proliferation and blocks apoptosis, determining cell survival (Buck et al., 1999, 2001; Buck & Chojkier, 2003). Furthermore, the LAP/LIP ratio is critical in C/EBP β-mediated gene transcription, and modulates the cell response to endoplasmic reticulum (ER) stress (Li et al., 2008).


“Gamma-aminobutyric acid-containing (GABAergic) interneuro


“Gamma-aminobutyric acid-containing (GABAergic) interneurons play an important role in the function of the cerebral cortex. Through mostly inhibitory mechanisms, interneurons control hyperexcitability, and synchronize and shape the spatiotemporal dynamics of cortical activity underlying various GDC-0449 datasheet brain functions. Their influence on cortical function is remarkably diverse, a reflection of the large variety of interneuronal populations that exist in the mammalian cortex. Research over the past few years has rapidly transformed our understanding of their mechanisms underlying the generation of different classes of interneurons. In this review, we summarize recent progress on this

process, progress which holds the promise of providing a rational framework for their classification, as well as means to understand their role in cortical processing. The cerebral cortex consists of two main classes of neurons, pyramidal

cells and interneurons, which respectively use glutamate and γ-aminobutyric acid (GABA) as main neurotransmitters. In the adult cortex, pyramidal cells are excitatory while GABA-containing (GABAergic) interneurons are typically inhibitory. Increasing evidence suggests that disruption of the excitatory–inhibitory balance maintained by pyramidal cells and interneurons is linked to the etiology of several neurological disorders (Rubenstein & Merzenich, 2003; Dani et al., 2005; Levitt, 2005; Lewis et al., 2005). Conversely, genes associated with such disorders have been shown to influence the development of PI3K inhibitor cortical interneurons (Erbel-Sieler et al.,

2004; Flames et al., 2007; Fazzari Racecadotril et al., 2010; Wen et al., 2010). Thus, disruption of GABAergic inputs to pyramidal cells might represent a common pathophysiological mechanism underlying multiple neuropsychiatric conditions. Interneurons comprise ∼20–30% of the cortical neuronal population and are locally projecting cells that control and synchronize the output of pyramidal neurons. Interestingly, the influence of GABAergic interneurons on pyramidal cells is largely dependent on the subcellular location of their inputs, which varies among different interneuron subtypes. Despite years of research, however, it is still unclear how many different types of cortical interneurons actually exist. This is due, among other reasons, to the difficulties that are inherent to the task of defining what a cortical interneuron is (Ascoli et al., 2008). Despite some reservations, today it is largely accepted that distinct types of interneurons exist; they are defined by a constellation of neurochemical, anatomical and electrophysiological characteristics. Based on this definition, several major classes of interneurons have been identified, although many other types of interneurons are left out of this major classification.